Xiong Zhaokang, Vice Chairman of the Standing Committee of the Wenshan Prefecture People's Congress, visited and investigated Runjia Pharmaceutical.
2024-11-11
Xiong Zhaokang, Vice Chairman of the Wenshan Prefecture People's Congress Standing Committee, visits Runjia Pharmaceutical
To promote the high-quality development of enterprises, understand the current situation of enterprise development, actively solve problems for enterprises, and work together to find solutions for development. On the morning of November 8, Xiong Zhaokang, Vice Chairman of the Wenshan Prefecture People's Congress Standing Committee, Huang Maowen, Deputy Director of the Wenshan Prefecture Sanqi Traditional Chinese Medicine Industry Development Center, and other leaders conducted a research and visit to Yunnan Runjia Pharmaceutical Co., Ltd..
In-depth visits to collect enterprise needs. Playing a bridging role, face-to-face communication with enterprise leaders to understand the difficulties faced by enterprises, and to sort out problems in production and operation, market marketing, and talent introduction.
Propaganda and guidance to optimize the business environment. Xiong Zhaokang, Vice Chairman of the Standing Committee of the Prefecture People's Congress, promoted policies benefiting enterprises, the business environment, and talent introduction. In response to the problems raised by enterprises, such as difficulties in talent introduction and lack of professional guidance on applying for preferential policies, he promptly conveyed the direction of industrial development to enterprises, encouraged qualified enterprises to actively develop according to policy guidance, and helped enterprises grow bigger and stronger. Improving satisfaction and initiative with practical actions to continuously optimize the business environment.
Finally, Xiong Zhaokang, Vice Chairman of the Standing Committee of the Prefecture People's Congress, proposed that as pharmaceutical companies, they should comply with regulations in production and strictly abide by relevant laws and regulations on pharmaceutical production. Ensure that the production process complies with Good Manufacturing Practice for pharmaceuticals, strengthen production process control, and ensure drug quality.
